A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns ...
Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...
5don MSN
Repligen outlines $810M–$840M 2026 revenue target while expanding analytics and protein franchises
Q4 2025 Management View Olivier Loeillot, President and CEO, emphasized a strong finish to 2025 with revenue of $198 million for the fourth quarter and $738 million for the full year, translating to ...
As of Tuesday, February 24, Repligen Corporation’s RGEN share price has dipped by 6.43%, which has investors questioning if ...
Repligen (RGEN) delivered earnings and revenue surprises of +11.26% and +2.96%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Recent earnings reports from FIS, Repligen, and DigitalOcean highlight growth and strategic shifts amid evolving market ...
For full year 2025, Repligen reported revenue of $738 million, up 16% YoY, with adjusted earnings per share of $1.71 compared to $1.58 in the prior year. The company expects adjusted operating margin ...
Fourth quarter revenue of $198 million, a year-over-year increase of 18% as reported, 14% organic with continued momentum in orders in the quarterFull year 2025 revenue of $738 million, a year-over-ye ...
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 18.1% year on year to $197.9 million. The ...
The company enters earnings with a forward price-to-earnings ratio of 81 times and a market capitalization of $7.64 billion. In its most recent quarter, Repligen beat expectations on both the top and ...
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be reporting results this Tuesday before market hours ...
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results